Tanaka Chemical Corporation

TSE:4080.T

753 (JPY) • At close September 13, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) JPY.

20232022202120202019201820172016201520142013201220112010200920082007
Revenue 47,98757,67240,53122,754.31620,073.98132,632.13521,413.10613,254.38515,266.17112,384.4710,660.6269,035.92210,257.57516,309.62216,110.72423,859.22224,042.358
Cost of Revenue 43,19953,45537,53120,895.03119,565.88631,438.01919,262.59512,388.41214,371.87211,459.4529,840.9498,782.4769,750.27514,595.74714,324.16122,946.87621,083.853
Gross Profit 4,7884,2173,0001,859.285508.0951,194.1162,150.511865.973894.299925.018819.677253.446507.31,713.8751,786.563912.3462,958.505
Gross Profit Ratio 0.10.0730.0740.0820.0250.0370.10.0650.0590.0750.0770.0280.0490.1050.1110.0380.123
Reseach & Development Expenses 418598642547.545546.657555.05463.571485.714483.452638.902579.502568.504773.644592.166542.663410.163374.444
General & Administrative Expenses 370354354256.017240.676260.74190.825152.44149.042108.24412.399257.636217.088401.431392.569423.627394.995
Selling & Marketing Expenses 1,22800000000003.3355.7669.0816.17613.52914.569
SG&A 1,598354354256.017240.676260.74190.825152.44149.042108.24412.399260.971222.854410.512398.745437.156409.564
Other Expenses -2-43-38.973-102.939-5.79-5.588-96.653-116.544-10.630.523-297.219-8.1-12.5132.2826.2443.492
Operating Expenses 2,0162,4412,1711,879.971,873.1661,688.1671,419.5651,272.6351,195.7511,318.5341,296.1431,380.7351,619.3361,319.5951,185.71,086.8811,003.186
Operating Income 2,7721,773825-20.687-1,365.073-494.053730.944-406.665-301.454-393.519-476.467-1,127.29-1,112.041195.872448.068-301.6011,738.808
Operating Income Ratio 0.0580.0310.02-0.001-0.068-0.0150.034-0.031-0.02-0.032-0.045-0.125-0.1080.0120.028-0.0130.072
Total Other Income Expenses Net -9-185-16-17.183-134.499-37.817-98.742-231.939635.577-2,263.801-232.713-236.104-86.408-103.816-73.858-152.703-154.837
Income Before Tax 2,7631,588809-37.87-1,499.572-531.87632.202-638.604334.123-2,657.32-709.18-1,363.394-1,198.44992.056374.21-454.3041,583.971
Income Before Tax Ratio 0.0580.0280.02-0.002-0.075-0.0160.03-0.0480.022-0.215-0.067-0.151-0.1170.0060.023-0.0190.066
Income Tax Expense 20729777376.494128.888-6.968-49.5892.0721.6046.4745.8715.914116.364-1.56539.361134.375718.013
Net Income 2,5551,290731-414.364-1,628.461-524.901681.792-640.674312.519-2,663.795-715.052-1,369.308-1,314.81393.621334.849-588.679865.958
Net Income Ratio 0.0530.0220.018-0.018-0.081-0.0160.032-0.0480.02-0.215-0.067-0.152-0.1280.0060.021-0.0250.036
EPS 78.5439.6522.47-12.74-50.06-19.1826.9-33.3321.05-188.96-51.62-108.25-103.957.426.73-47.5469.93
EPS Diluted 78.5439.6522.47-12.74-50.06-19.1826.9-33.3321.05-188.96-51.62-108.25-103.957.426.45-47.5463.05
EBITDA 4,9083,6532,5481,345.395-611.148117.5841,151.519238.298611.074843.369796.693-321.001359.2342,139.5922,507.7931,462.132,847.44
EBITDA Ratio 0.1020.0630.0630.059-0.030.0040.0540.0180.040.0680.075-0.0360.0350.1310.1560.0610.118